World Orphan Drug Virtual Conference
- Eamon Mulvaney
- Aug 18, 2020
- 1 min read
Updated: Mar 29, 2022
Well done to the ATXA Team, who gave a presentation at the World Orphan Drug Virtual Conference on Monday 17th August. They presented on NTP42 an antagonist of the thromboxane receptor, attenuates experimentally induced pulmonary arterial hypertension (PAH).
